Fly Tumor Points Way To New Understanding Of Cancer Development

February 01, 1999



February 1, 1999
-- Howard Hughes Medical Institute (HHMI) researchers at Yale University have "rescued" fruit flies from cancerous tumors by inserting a cancer-suppressing human gene into the insects. The scientists believe that their achievement represents the first direct link between human tumor suppressor genes and those found in the fruit fly Drosophila.

More broadly, the experiments demonstrate that even though flies and humans are separated by 800 million years of evolution, the insects can provide important new insights into human cancers, says HHMI investigator Tian Xu at Yale University School of Medicine.

Tumor suppressor genes produce proteins that normally stop cell proliferation.When such genes malfunction, they produce defective proteins that permit cells to proliferate endlessly, producing tumors.

In a paper published in the February 1999 issue of the journal Nature Genetics, the researchers showed that inserting the human "large tumor suppressor" (LATS1) gene into Drosophila that lacked the fly version of the gene (lats) prevented tumor formation. Flies with the human LATS1 gene did not show the widespread tumors and early mortality caused by the non-functioning lats gene, suggesting that the two genes have the same function.

In addition, Xu and his colleagues uncovered evidence that lats is a new kind of tumor suppressor that blocks a specific stage of cell proliferation. "We believe this finding represents a major advance in understanding cell cycle regulation, and thus cancer biology, because these LATS molecules are a new type of negative regulator for the enzymes that drive the cell cycle," said Xu.Thus, he said, the finding hints that further explorations into the molecular signaling machinery involving LATS1 may yield insights into little-understood cancers and perhaps lead to new cancer therapies.

In another set of experiments, which were described in a second paper in the February 1999 issue of Nature Genetics, Xu's team disrupted the LATS1 gene in mice. The scientists found that mice developed ovarian tumors, soft-tissue sarcomas and pituitary disorders.

"This finding is important because it is the first example showing that an invertebrate tumor suppressor is also a tumor suppressor in mammals," said Xu. "This also suggests that some human cancers may be caused by a mutation of the LATS1 gene, although the correlation between mice and humans is not that good in terms of the types of tumors caused by a particular mutation."

In a commentary on the two papers, cancer researcher Christopher Kemp of the Fred Hutchinson Cancer Research Center in Seattle noted that even though many tumor suppressor genes have been identified in flies, they "had not gained broad acceptance or notice in the mammalian cancer genetics community."

But the two papers by Xu and his colleagues, "take the study of fly cancer to a new level," wrote Kemp in the February 1999 issue of Nature Genetics."These show, apparently for the first time, that a gene functions as a tumor suppressor in both invertebrates and vertebrates. In two fell swoops, the authors have thrust a previously obscure fly mutation to the center of the cell cycle and mammalian cancer."

A key to the experiments was Xu's team's technique for producing "genetic mosaic" fruit flies.In such mosaics, researchers can manipulate selected cells to give them two copies of a defective tumor suppressor.

"These mosaic flies are like cancer patients, in that very few cells possess mutated tumor suppressors, consequently developing tumors," explained Xu."Most of the cells in both the flies' and the human patients' bodies carry normal copies of these genes.

"We believe that with this new technique we have shown that just as in many other aspects of biology, Drosophila will prove an excellent model to study tumor development, and that the process in flies will prove directly relevant to what happens in mammals, including humans," said Xu.
-end-


Howard Hughes Medical Institute

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.